Status:

COMPLETED

Virtual Ward for Home Dialysis

Lead Sponsor:

Christopher Chan

Collaborating Sponsors:

Baxter Healthcare Corporation

Vancouver General Hospital

Conditions:

End Stage Renal Disease

Kidney Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Home based renal replacement therapy (RRT), including peritoneal dialysis (PD) and home hemodialysis(HHD), offers enhanced quality of life and clinical advantages compared to conventional in-center he...

Detailed Description

End stage renal disease (ESRD) is kidney disease that requires dialysis or kidney transplant to replace lost kidney function. The most common renal replacement therapy in North America is conventional...

Eligibility Criteria

Inclusion

  • Patient in the home dialysis program (PD and HHD)and on of the following:
  • Discharge from hospital following an inpatient admissions
  • Medical procedure (e.g. vascular access procedure).
  • Treatment with antibiotics.
  • Completion of home dialysis training program.

Exclusion

  • Decline consent.
  • Unable to participate - (e.g. no phone at home, language barrier)

Key Trial Info

Start Date :

September 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2016

Estimated Enrollment :

215 Patients enrolled

Trial Details

Trial ID

NCT01912001

Start Date

September 1 2013

End Date

March 1 2016

Last Update

May 12 2016

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

University of Alberta

Edmonton, Alberta, Canada, T6G 2V2

2

Vancouver General Hospital

Vancouver, British Columbia, Canada, V6H 0A5

3

Capital District Health Authority

Halifax, Nova Scotia, Canada, B3H 1V7

4

The Ottawa Hospital

Ottawa, Ontario, Canada, K1H 1A2